Trial intelligence / Profile preview

Ketamine Infusion for Acute Pain in Rib Fracture Patients

NCT02432456Phase 4

Key facts

Status: Completed
Start: Sep 2015
Primary completion: Aug 2018
Countries: 1
Sponsor: Medical College of Wisconsin
Modality: Small Molecules

Drugs: ketamine
Conditions: acute pain

Overview

Phase 4, randomised, double-blind trial in acute pain comparing Ketamine Infusion with Placebo Infusion (2 arms). Primary endpoint: Visual Analog Numeric Pain Score. Started Sep 2015; status: completed.

Design

2 arms

Study design: RandomizedDouble-blind

Ketamine Infusion
Ketamine infusion + Standard of Care
Placebo Infusion
Placebo infusion + Standard of Care

Endpoints

Primary

Visual Analog Numeric Pain Score12-24 hours post infusion

Secondary

Visual Analog Numeric Pain Score24-48 hours post infusion
Oral Morphine Equivalent (Narcotic Usage)24-48 hours post infusion
Length of StayTotal Index Hospitalization up to 365 days
Regional Anesthesia UtilizationTotal Index Hospitalization up to 365 days
Respiratory FailureTotal Index Hospitalization up to 365 days
HallucinationTotal Index Hospitalization up to 365 days
Oral Morphine Equivalent (Narcotic Usage) in Severely InjuredTotal Index Hospitalization up to 365 days

Beyond the preview

Go deeper on NCT02432456.

Full results, competitive context and analysis are in the Gosset platform.

Full results & analysis

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02432456.